Insights On Partnering

31. Open-Label Study Assessing Relative And Absolute Bioavailability 1/26/2026

    Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

32. How Community-Based Research Models Expand Access 9/9/2025

    As momentum continues to grow in neurology research, how can community-based research models help overcome recruitment and retention challenges in complex areas like Alzheimer's?

33. The Site-Sponsor Digital Divide Is Slowing Clinical Trial Innovation 5/11/2026

    Clinical trial site digitization often stalls due to operational, cultural, and structural barriers. Site-centered workflows can overcome these, boosting efficiency, visibility, and execution.

34. Enhancing Phase 1 Clinical Trials With Point-Of-Need Safety Assessments 2/3/2025

    A Mobile Clinical Suite (MCS) proved to be the solution that Syneos Health needed to resolve their Phase 1 study trial challenges with comprehensive eye exams.

35. Case Management Accelerates Shipment For SCN1A+ Dravet Syndrome Gene Therapy 3/12/2026

    Consider this streamlined, end-to-end solution that helped safeguard study timelines and ensured that patients with urgent medical needs could receive treatment without delay.

36. Delivering Successful Cell And Gene Therapy Trials 9/10/2025

    Successfully executing complex cell and gene therapy trials hinges on meticulous operational strategies and a patient-centric approach.

37. Podcast — Strategic Site Identification: A Proven Approach 11/20/2024

    Watch our new podcast to discover Altasciences' unique process for identifying and selecting the right clinical sites for your unique project.

38. Breaking Through Barriers With Integrated Trial Optimization 5/9/2025

    In today’s complex clinical trial environment, optimizing trial design requires a multidimensional strategy that balances scientific rigor with real-world constraints.

39. Key Strategies For Clinical Development In Rare Cancers 2/11/2025

    Successful execution of rare cancer clinical trials requires strategic patient recruitment, innovative trial design, and specialized expertise from Oncology CROs.

40. Accelerating A Global, FIH ADC Therapy Trial For Lung Cancer 11/17/2025

    Choose a development partner who can navigate global execution, ADC-specific challenges, and Project Optimus requirements so your first-in-human study is designed and positioned for success.